drugset / Trial / NCT02095145

Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance

NCT02095145 ↗

Phase 2 Completed 38 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupDouble-blindPrevention

Summary

This randomized phase II trial studies pomegranate-extract pill in preventing tumor growth in patients with prostate cancer that is limited to a certain part of the body (localized), who have chosen observation as their treatment plan. The use of pomegranate-extract pill may slow disease progression in patients with localized prostate cancer.

Timeline

Start
2014-05-08
Primary completion
2018-01-23
Completion
2019-09-26

Drugs

EvaluationDrugModalityDoseRoute
Subject pomegranate fruit extract Unknown 1000 mg Oral